adenosine has been researched along with Drug Withdrawal Symptoms in 44 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 6 (13.64) | 18.7374 |
1990's | 18 (40.91) | 18.2507 |
2000's | 13 (29.55) | 29.6817 |
2010's | 4 (9.09) | 24.3611 |
2020's | 3 (6.82) | 2.80 |
Authors | Studies |
---|---|
Chern, Y; Choi, DS; Essa, H; León, BE; Peyton, L | 1 |
Couto, GT; da Silva, GP; da Silva, JS; Da Silva, RS; Rockenbach, L; Vianna, MRMR | 1 |
Bennett, GJ; Chen, Z; Cuzzocrea, S; Dalgarno, R; Doyle, TM; Esposito, E; Fan, C; Hutchinson, MR; Jacobson, KA; Largent-Milnes, TM; Salvemini, D; Staikopoulos, V; Tosh, DK; Trang, T; Vanderah, TW | 1 |
Antkiewicz-Michaluk, L; Baranowska-Bosiacka, I; Chlubek, D; Fidecka, S; Gutowska, I; Listos, J; Listos, P; Orzelska-Górka, J; Pilutin, A; Talarek, S; Tarnowski, M; Tkacz, M; Wąsik, A; Łupina, M | 1 |
Chiu, VM; Hill, HH; Sorg, BA; Todd, RP; Zhang, X | 1 |
Capasso, A; Gallo, C | 1 |
Engemann, S; Sahota, P; Sharma, R; Thakkar, MM | 1 |
Butler, TR; Prendergast, MA | 1 |
Berrino, L; Capuano, A; De Novellis, V; Filippelli, A; Mazzeo, F; Rossi, F; Stella, L; Vitelli, MR | 1 |
Floras, JS; Notarius, CF; Rongen, GA | 1 |
Christie, MJ; Hack, SP; Vaughan, CW | 1 |
Bailey, A; Gianotti, R; Ho, A; Kreek, MJ | 1 |
Hoexter, MQ; Mello, LE; Rosa, PS; Tufik, S | 1 |
Fidecka, S; Listos, J; Malec, D | 1 |
Shapiro, RE | 1 |
Fidecka, S; Listos, J; Talarek, S | 1 |
Braden, BB; Butler, TR; Prendergast, MA; Self, RL; Smith, KJ | 1 |
Collier, HO; Tucker, JF | 1 |
Collier, HO; Plant, NT; Tucker, JF; von Uexküll, A | 1 |
Dar, MS; Mustafa, SJ; Wooles, WR | 1 |
Daly, JW; Jacobson, KA; Nikodijević, O | 1 |
Contreras, E; Germany, A | 1 |
Biaggioni, I; Kurunwune, B; Paul, S | 1 |
Kaplan, GB; Sears, MT | 1 |
Biggio, G; Concas, A; Cuccheddu, T; Floris, S; Mascia, MP; Mostallino, MC; Perra, C; Satta, S | 1 |
Aley, KO; Levine, JD | 1 |
Ando, S; Brooks, SC; Floras, JS; Notarius, CF; Rongen, GA | 1 |
Bockaert, J; Manzoni, O; Pujalte, D; Williams, J | 1 |
Delfs, J; Shoji, Y; Williams, JT | 1 |
Naghipour, B; Roushan-zamir, F; Shafaghi, B; Zarrindast, MR | 1 |
Hope, W; Salem, A | 1 |
Angel, M; Biaggioni, I; Cavalcante, J; Christman, B; Costa, F; Haile, V; Sulur, P | 1 |
Gatch, MB; Lal, H; Wallis, CJ | 1 |
Adams, WR; Bharmal, NH; Kaplan, GB; Leite-Morris, KA | 1 |
Baldo, BA; Koob, GF; Markou, A | 1 |
Capasso, A | 1 |
Fathollahi, Y; Khalili, M; Semnanian, S | 1 |
Coupar, IM; Tran, BL | 1 |
Coupar, IM; Dionyssopoulos, T; Hope, W | 1 |
Arzubiaga, C; Biaggioni, I; Paul, S; Puckett, A | 1 |
Contreras, E; Germany, A; Quijada, L; Villar, M | 1 |
Green, RM; Stiles, GL | 1 |
Tse, SY; Wei, ET | 1 |
Conlay, LA; Evoniuk, G; Wurtman, RJ | 1 |
3 review(s) available for adenosine and Drug Withdrawal Symptoms
Article | Year |
---|---|
Neuroadaptations in adenosine receptor signaling following long-term ethanol exposure and withdrawal.
Topics: Adaptation, Physiological; Adenosine; Alcohol Drinking; Animals; Ethanol; Humans; Receptors, Purinergic P1; Signal Transduction; Substance Withdrawal Syndrome; Time Factors | 2012 |
Caffeine and headaches.
Topics: Adenosine; Brain; Caffeine; Drug Combinations; Drug Synergism; Headache Disorders; Headache Disorders, Secondary; Humans; Purinergic P1 Receptor Agonists; Receptors, Purinergic P1; Substance Withdrawal Syndrome | 2007 |
Sites and mechanisms of dependence in the myenteric plexus of guinea pig ileum.
Topics: Acetylcholine; Adenosine; Animals; Clonidine; Cyclic AMP; Guinea Pigs; Humans; Ileum; In Vitro Techniques; Morphine; Morphine Dependence; Morphine Derivatives; Muscle Contraction; Muscle, Smooth; Myenteric Plexus; Naloxone; Pertussis Vaccine; Scopolamine; Substance P; Substance Withdrawal Syndrome; Substance-Related Disorders; Theophylline; Yohimbine | 1984 |
41 other study(ies) available for adenosine and Drug Withdrawal Symptoms
Article | Year |
---|---|
N
Topics: Adenosine; Alcohol Drinking; Alcoholism; Animals; Anxiety; Male; Mice; Mice, Inbred C57BL; Substance Withdrawal Syndrome | 2022 |
Anticonvulsant Role of Adenosine is Blunted During Alcohol Withdrawal Syndrome in an Adult Zebrafish Model.
Topics: Adenosine; Alcoholism; Animals; Anticonvulsants; Ethanol; Receptors, Purinergic P1; Seizures; Substance Withdrawal Syndrome; Zebrafish | 2023 |
Chronic Morphine-Induced Changes in Signaling at the A
Topics: Adenosine; Analgesics; Animals; Drug Tolerance; Female; Hyperalgesia; Interleukin-10; Interleukin-1beta; Male; Morphine; Rats; Rats, Sprague-Dawley; Receptor, Adenosine A3; Signal Transduction; Substance Withdrawal Syndrome; Time Factors | 2020 |
The adenosinergic system is involved in sensitization to morphine withdrawal signs in rats-neurochemical and molecular basis in dopaminergic system.
Topics: Adenosine; Analgesics, Opioid; Animals; Behavior, Animal; Dopamine; Male; Morphine; Morphine Dependence; Naloxone; Narcotic Antagonists; Rats; Rats, Wistar; Receptors, Dopamine; RNA, Messenger; Substance Withdrawal Syndrome | 2016 |
Neuronal metabolomics by ion mobility mass spectrometry in cocaine self-administering rats after early and late withdrawal.
Topics: Adenosine; Animals; Cocaine; Corpus Striatum; Creatine; Glutathione; Humans; Male; Mass Spectrometry; Metabolomics; Neurons; Nucleus Accumbens; Prefrontal Cortex; Rats; Rats, Sprague-Dawley; Substance Withdrawal Syndrome; Time Factors | 2016 |
Functional interaction between purinergic system and opioid withdrawal: in vitro evidence.
Topics: Adenosine; Adenosine A1 Receptor Agonists; Adenosine A1 Receptor Antagonists; Adenosine A2 Receptor Agonists; Adenosine A2 Receptor Antagonists; Adenosine Triphosphate; Analgesics, Opioid; Animals; Caffeine; Dipyridamole; Dose-Response Relationship, Drug; Guinea Pigs; Ileum; In Vitro Techniques; Male; Morphine; Morphine Dependence; Muscle, Smooth; Naloxone; Narcotic Antagonists; Narcotics; Phenethylamines; Purinergic P2 Receptor Agonists; Purinergic P2 Receptor Antagonists; Quinidine; Receptor, Adenosine A1; Receptors, Adenosine A2; Receptors, Purinergic P2; Substance Withdrawal Syndrome; Theobromine; Theophylline | 2009 |
Role of adenosine and wake-promoting basal forebrain in insomnia and associated sleep disruptions caused by ethanol dependence.
Topics: Adenosine; Alcoholism; Animals; Carrier Proteins; Cell Count; Equilibrative Nucleoside Transporter 1; Immunohistochemistry; Male; Microdialysis; Prosencephalon; Proto-Oncogene Proteins c-fos; Rats; Rats, Sprague-Dawley; Receptor, Adenosine A1; Reverse Transcriptase Polymerase Chain Reaction; RNA; Sleep; Sleep Deprivation; Sleep Initiation and Maintenance Disorders; Sleep Wake Disorders; Sleep, REM; Substance Withdrawal Syndrome; Wakefulness | 2010 |
Interactive role of adenosine and dopamine in the opiate withdrawal syndrome.
Topics: Adenosine; Adenosine A1 Receptor Agonists; Adenosine A2 Receptor Antagonists; Animals; Caffeine; Chromatography, High Pressure Liquid; Dopamine; Injections, Subcutaneous; Male; Microdialysis; Morphine; Pyrimidines; Rats; Rats, Wistar; Receptors, Dopamine; Substance Withdrawal Syndrome; Triazoles | 2003 |
Caffeine and coffee tolerance.
Topics: Adenosine; Baroreflex; Blood Pressure; Caffeine; Coffee; Drug Tolerance; Heart Rate; Humans; Hypertension; Infusions, Intravenous; Muscles; Purinergic P1 Receptor Antagonists; Substance Withdrawal Syndrome; Sympathetic Nervous System; Vasomotor System | 2003 |
Modulation of GABA release during morphine withdrawal in midbrain neurons in vitro.
Topics: Action Potentials; Adenosine; Affinity Labels; Animals; Colforsin; Cyclic AMP; Dipyridamole; Dose-Response Relationship, Drug; Drug Interactions; Enkephalins; Enzyme Inhibitors; gamma-Aminobutyric Acid; In Vitro Techniques; Isoquinolines; Male; Mesencephalon; Mice; Mice, Inbred C57BL; Morphine; Morphine Dependence; Naloxone; Narcotic Antagonists; Narcotics; Neural Inhibition; Neurons; Patch-Clamp Techniques; Periaqueductal Gray; Probenecid; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Substance Withdrawal Syndrome; Sulfonamides; Synaptic Transmission; Thioinosine; Time Factors; Uricosuric Agents; Vasodilator Agents; Xanthines | 2003 |
Persistent upregulation of mu-opioid, but not adenosine, receptors in brains of long-term withdrawn escalating dose "binge" cocaine-treated rats.
Topics: Adenosine; Analgesics, Opioid; Animals; Autoradiography; Behavior, Animal; Brain; Brain Mapping; Cocaine; Dopamine Uptake Inhibitors; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Male; Phenethylamines; Protein Binding; Purinergic P1 Receptor Antagonists; Rats; Rats, Inbred F344; Receptors, Opioid, mu; Receptors, Purinergic P1; Substance Withdrawal Syndrome; Tritium; Up-Regulation; Xanthines | 2005 |
Consequences of prolonged caffeine administration and its withdrawal on pilocarpine- and kainate-induced seizures in rats.
Topics: Adenosine; Animals; Caffeine; Coffea; Disease Models, Animal; Dose-Response Relationship, Drug; Drinking Behavior; Epilepsy, Temporal Lobe; Kainic Acid; Male; Pilocarpine; Rats; Rats, Wistar; Seizures; Status Epilepticus; Substance Withdrawal Syndrome | 2005 |
Influence of adenosine receptor agonists on benzodiazepine withdrawal signs in mice.
Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); Animals; Anti-Anxiety Agents; Anticonvulsants; Benzodiazepines; Diazepam; Dose-Response Relationship, Drug; Flumazenil; Male; Mice; Pentylenetetrazole; Phenethylamines; Purinergic Agonists; Purinergic P1 Receptor Agonists; Purinergic P2 Receptor Agonists; Seizures; Substance Withdrawal Syndrome; Temazepam | 2005 |
Adenosine receptor agonists attenuate the development of diazepam withdrawal-induced sensitization in mice.
Topics: Adenosine; Adenosine A1 Receptor Agonists; Adenosine A2 Receptor Agonists; Adenosine-5'-(N-ethylcarboxamide); Animals; Convulsants; Diazepam; Hypnotics and Sedatives; Male; Mice; Pentylenetetrazole; Phenethylamines; Purinergic P1 Receptor Agonists; Seizures; Substance Withdrawal Syndrome; Substance-Related Disorders | 2008 |
Sex differences in the neurotoxic effects of adenosine A1 receptor antagonism during ethanol withdrawal: reversal with an A1 receptor agonist or an NMDA receptor antagonist.
Topics: Adenosine; Adenosine A1 Receptor Agonists; Adenosine A1 Receptor Antagonists; Animals; Cell Survival; Central Nervous System Depressants; Ethanol; Female; Hippocampus; Immunohistochemistry; Male; Neurotoxicity Syndromes; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Sex Characteristics; Substance Withdrawal Syndrome; Tissue Culture Techniques; Xanthines | 2008 |
Inhibition by adenosine analogs of opiate withdrawal effects.
Topics: 2-Chloroadenosine; Adenosine; Animals; Behavior, Animal; Chlordiazepoxide; Guinea Pigs; Humans; Ileum; Male; Mice; Mice, Inbred Strains; Morphine Dependence; Morphine Derivatives; Muscle Contraction; Myenteric Plexus; Naloxone; Receptors, Cell Surface; Receptors, Purinergic; Substance Withdrawal Syndrome | 1984 |
Possible role of adenosine in the CNS effects of ethanol.
Topics: Adenosine; Alcoholic Intoxication; Alcoholism; Animals; Body Temperature; Central Nervous System; Dipyridamole; Ethanol; Humans; Male; Motor Activity; Rats; Rats, Inbred Strains; Receptors, Cell Surface; Receptors, Purinergic; Substance Withdrawal Syndrome; Theophylline | 1983 |
Locomotor activity in mice during chronic treatment with caffeine and withdrawal.
Topics: 1-Methyl-3-isobutylxanthine; Adenosine; Animals; Caffeine; Dopamine Agents; Dose-Response Relationship, Drug; Male; Mice; Motor Activity; Parasympathomimetics; Substance Withdrawal Syndrome; Xanthines | 1993 |
Purinergic drugs and calcium channel antagonists attenuate the withdrawal syndrome from barbital.
Topics: Adenosine; Animals; Barbital; Behavior, Animal; Calcium Channel Blockers; Drug Tolerance; Male; Mice; Purinergic Agonists; Substance Withdrawal Syndrome; Substance-Related Disorders | 1994 |
Caffeine withdrawal: apparent heterologous sensitization to adenosine and prostacyclin actions in human platelets.
Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); Adolescent; Adult; Alprostadil; Blood Platelets; Caffeine; Epoprostenol; Humans; Male; Models, Biological; Purinergic P1 Receptor Antagonists; Receptors, Epoprostenol; Receptors, Prostaglandin; Receptors, Purinergic P1; Sensitivity and Specificity; Substance Withdrawal Syndrome; Up-Regulation | 1993 |
Adenosine receptor agonists attenuate and adenosine receptor antagonists exacerbate opiate withdrawal signs.
Topics: Adenosine; Animals; Male; Mice; Mice, Inbred Strains; Morphine; Motor Activity; Phenethylamines; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Substance Withdrawal Syndrome | 1996 |
Chronic ethanol intoxication enhances [3H]CCPA binding and does not reduce A1 adenosine receptor function in rat cerebellum.
Topics: Adenosine; Alcoholism; Animals; Cerebellar Cortex; Cerebellum; Dose-Response Relationship, Drug; Ethanol; Isoniazid; Male; Membranes; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Rats; Rats, Sprague-Dawley; Receptors, Purinergic P1; Seizures; Substance Withdrawal Syndrome; Tremor; Xanthines | 1996 |
Multiple receptors involved in peripheral alpha 2, mu, and A1 antinociception, tolerance, and withdrawal.
Topics: Adenosine; Adrenergic alpha-2 Receptor Agonists; Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Analgesics; Analgesics, Opioid; Animals; Clonidine; Dinoprostone; Drug Interactions; Drug Tolerance; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Enkephalins; Hyperalgesia; Male; Models, Biological; Naloxone; Narcotic Antagonists; Oligonucleotides, Antisense; Purinergic P1 Receptor Agonists; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-2; Receptors, Opioid, mu; Receptors, Purinergic P1; Second Messenger Systems; Substance Withdrawal Syndrome; Substance-Related Disorders; Xanthines; Yohimbine | 1997 |
Caffeine abstinence augments the systolic blood pressure response to adenosine in humans.
Topics: Adenosine; Adult; Blood Pressure; Caffeine; Heart Rate; Humans; Male; Middle Aged; Purinergic P1 Receptor Antagonists; Receptors, Purinergic P1; Substance Withdrawal Syndrome | 1998 |
Decreased presynaptic sensitivity to adenosine after cocaine withdrawal.
Topics: 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone; Adenosine; Affinity Labels; Animals; Cocaine; Dipyridamole; Dopamine Uptake Inhibitors; Excitatory Postsynaptic Potentials; Glutamic Acid; Hippocampus; Male; Nucleus Accumbens; Phosphodiesterase Inhibitors; Presynaptic Terminals; Purinergic P1 Receptor Agonists; Rats; Rats, Sprague-Dawley; Stimulation, Chemical; Substance Withdrawal Syndrome; Substance-Related Disorders; Theophylline; Thioinosine; Vasodilator Agents; Xanthines | 1998 |
Presynaptic inhibition of GABA(B)-mediated synaptic potentials in the ventral tegmental area during morphine withdrawal.
Topics: Adenosine; Adenylyl Cyclases; Animals; Drug Synergism; Enzyme Activation; Guinea Pigs; Morphine; Narcotics; Neural Inhibition; Phosphotransferases; Presynaptic Terminals; Receptors, Dopamine D1; Receptors, GABA-B; Receptors, Opioid, kappa; Receptors, Opioid, mu; Substance Withdrawal Syndrome; Synaptic Transmission; Tegmentum Mesencephali | 1999 |
Effects of adenosine receptor agents on the expression of morphine withdrawal in mice.
Topics: Adenosine; Analysis of Variance; Animals; Behavior, Animal; Diarrhea; Male; Mice; Mice, Inbred Strains; Morphine; Morphine Dependence; Naloxone; Narcotic Antagonists; Narcotics; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Substance Withdrawal Syndrome; Theobromine; Xanthines | 1999 |
Role of endogenous adenosine in the expression of opiate withdrawal in rats.
Topics: Adenosine; Animals; Chromatography, High Pressure Liquid; Corpus Striatum; Hypoxanthine; Inosine; Male; Microdialysis; Naloxone; Narcotic Antagonists; Narcotics; Nucleus Accumbens; Rats; Rats, Wistar; Substance Withdrawal Syndrome | 1999 |
Intravascular source of adenosine during forearm ischemia in humans: implications for reactive hyperemia.
Topics: Adenosine; Adult; Caffeine; Female; Forearm; Humans; Hyperemia; Ischemia; Male; Microdialysis; Muscle, Skeletal; Reference Values; Regional Blood Flow; Substance Withdrawal Syndrome; Thromboxanes; Time Factors | 1999 |
The effects of adenosine ligands R-PIA and CPT on ethanol withdrawal.
Topics: Adenosine; Alcohol Drinking; Animals; Anti-Anxiety Agents; Central Nervous System Depressants; Ethanol; Male; Maze Learning; Purinergic P1 Receptor Agonists; Rats; Rats, Long-Evans; Substance Withdrawal Syndrome; Theophylline | 1999 |
Role of adenosine A1 and A2A receptors in the alcohol withdrawal syndrome.
Topics: Adenosine; Animals; Brain; Central Nervous System Depressants; Ethanol; Male; Mice; Phenethylamines; Purinergic P1 Receptor Agonists; Receptor, Adenosine A2A; Receptors, Purinergic P1; Substance Withdrawal Syndrome; Thioinosine | 1999 |
Role of adenosine A2 receptors in brain stimulation reward under baseline conditions and during cocaine withdrawal in rats.
Topics: Adenosine; Animals; Brain; Caffeine; Cocaine; Differential Threshold; Dopamine Uptake Inhibitors; Drug Interactions; Electric Stimulation; Male; Phenethylamines; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Rats; Rats, Wistar; Reaction Time; Receptors, Purinergic P1; Reference Values; Reward; Substance Withdrawal Syndrome; Theobromine | 1999 |
Adenosine receptors are involved in the control of acute naloxone-precipitated withdrawal: in vitro evidence.
Topics: Adenosine; Animals; Caffeine; Dipyridamole; Guinea Pigs; Ileum; In Vitro Techniques; Male; Naloxone; Narcotic Antagonists; Phenethylamines; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Receptors, Purinergic P1; Substance Withdrawal Syndrome; Theobromine; Theophylline | 2000 |
Caffeine increases paragigantocellularis neuronal firing rate and induces withdrawal signs in morphine-dependent rats.
Topics: Adenosine; Analgesics, Opioid; Animals; Caffeine; Electrophysiology; Male; Medulla Oblongata; Microinjections; Morphine; Morphine Dependence; Neurons; Purinergic P1 Receptor Agonists; Rats; Substance Withdrawal Syndrome; Theophylline | 2001 |
Withdrawal and bidirectional cross-withdrawal responses in rats treated with adenosine agonists and morphine.
Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); Animals; Behavior, Animal; Female; Injections, Subcutaneous; Male; Morphine; Morphine Dependence; Muscle Contraction; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Purinergic P2 Receptor Agonists; Purinergic P2 Receptor Antagonists; Rats; Rats, Wistar; Substance Withdrawal Syndrome; Theobromine; Xanthines | 2001 |
Effect of adenosine analogues on the expression of opiate withdrawal in rats.
Topics: Adenosine; Animals; Behavior, Animal; Clonidine; Diarrhea; Female; Male; Morphine Dependence; Motor Activity; Naloxone; Rats; Rats, Inbred Strains; Substance Withdrawal Syndrome | 1992 |
Caffeine and theophylline as adenosine receptor antagonists in humans.
Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); Adult; Caffeine; Heart Rate; Humans; Male; Platelet Aggregation; Purinergic Antagonists; Receptors, Purinergic; Substance Withdrawal Syndrome; Theophylline | 1991 |
Influence of adenosine analogs on morphine tolerance and dependence in mice.
Topics: Adenosine; Animals; Calcium; Drug Tolerance; Mice; Morphine Dependence; Naloxone; Substance Withdrawal Syndrome | 1990 |
Chronic caffeine ingestion sensitizes the A1 adenosine receptor-adenylate cyclase system in rat cerebral cortex.
Topics: Adenosine; Adenylyl Cyclases; Animals; Caffeine; Cerebral Cortex; Cross-Linking Reagents; Guanine Nucleotides; Kinetics; Male; Phenylisopropyladenosine; Rats; Rats, Inbred Strains; Receptors, Adrenergic, beta; Receptors, Cell Surface; Receptors, Purinergic; Substance Withdrawal Syndrome; Time Factors | 1986 |
Inhibition of the shake response in rats by adenosine and 2-chloroadenosine.
Topics: 2-Chloroadenosine; Adenosine; Animals; Behavior, Animal; Cold Temperature; Dose-Response Relationship, Drug; Male; Morphine; Muscle Relaxants, Central; Rats; Shivering; Substance Withdrawal Syndrome | 1986 |
Endogenous adenosine and hemorrhagic shock: effects of caffeine administration or caffeine withdrawal.
Topics: Adenosine; Animals; Blood Pressure; Caffeine; Male; Rats; Rats, Inbred Strains; Shock, Hemorrhagic; Substance Withdrawal Syndrome; Time Factors | 1988 |